Moneycontrol
HomeNewsBusinessCOVID-19 | ‘Be back in office by September,’ Morgan Stanley CEO gives ultimatum to NY employees: Report
Trending Topics

COVID-19 | ‘Be back in office by September,’ Morgan Stanley CEO gives ultimatum to NY employees: Report

Gorman made sure to state that the policy would “not be dictatorial” and flexibility would continue as working parents still need to be home with children.

June 18, 2021 / 14:23 IST
Story continues below Advertisement
Morgan Stanley CEO James Gorman said the return to work policy will be “case-by-case” as "I don't think making a blanket statement to all employees is helpful" (Image: Shutterstock)

James Gorman, CEO of Morgan Stanley (MS), has told employees in the Wall Street top-dog’s New York offices to either get back to the offices by September, “or else”.

Gorman said that as more people are vaccinated against COVID-19 and life is slowly returning to normal, “it is time” employees head back to the offices, CNN reported.

Story continues below Advertisement

"If you can go to a restaurant in New York City, you can come into the office. And we want you in the office," Gorman said. He was speaking at an annual investing conference on June 14.

Follow our LIVE blog on the COVID-19 pandemic here

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show